Kargbo Robert B
Usona Institute, Fitchburg, Wisconsin 53711-5300, United States.
ACS Med Chem Lett. 2023 Jun 9;14(7):884-885. doi: 10.1021/acsmedchemlett.3c00220. eCollection 2023 Jul 13.
This Patent Highlight presents a method to treat inflammatory or neurological disorders in subjects needing treatment. The method involves administering a therapeutically effective amount of a composition containing a subhallucinogenic concentration of substituted phenethylamine. The substituted phenethylamine may belong to the 2C-X family, including 2C-H, 2C-I, 2C-B, or 2C-E. The specific concentration depends on the chronic inflammation's severity, with 25 mg for mild, 50 mg for moderate, and 100 mg for severe cases.
本专利亮点介绍了一种治疗有治疗需求受试者的炎症性或神经性疾病的方法。该方法包括给予治疗有效量的含有亚致幻浓度取代苯乙胺的组合物。取代苯乙胺可属于2C-X家族，包括2C-H、2C-I、2C-B或2C-E。具体浓度取决于慢性炎症的严重程度，轻度病例为25毫克，中度病例为50毫克，重度病例为100毫克。
